NovaBay Pharmaceuticals, Inc. Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2023.
  • NovaBay Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $9K, a 30.8% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $44K.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2023 was $51K, a 57.5% decline from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2022 was $120K, a 103% increase from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Depreciation for 2021 was $59K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $51K -$69K -57.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $120K +$61K +103% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $59K Jan 1, 2021 Dec 31, 2021 10-K 2022-03-29
2015 $164K -$68K -29.3% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-04
2014 $232K -$82K -26.1% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-04
2013 $314K -$27K -7.92% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $341K -$84K -19.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
2011 $425K -$2K -0.47% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-06
2010 $427K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.